Key Takeaway: Celldex (NASDAQ:CLDX) will participate in a fireside chat at the Cantor Global Healthcare Conference on September 10, 2026. The presentation will be available via webcast, with replays accessible for 90 days post-event. The company continues to advance its mission of developing innovative antibody-based therapies for immune-related disorders.
Price reaction · baseline $39.12 (2026-09-08 close) · hit after-hours · clean, no other CLDX news in the window
day 0 close · peak
-0.9%
Market Sentiment Analysis
POSITIVE FACTORS
Celldex is actively engaging with investors at a major conference.
The company is focused on pioneering new therapies in immunology.
The webcast allows broader access to their presentation.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+77%
120-day peak, hindsight
Typical move
2.4%
average across 7 past catalysts
Cash runway
~35 mo
Minimal dilution risk
Lead asset
Barzolvolimab
Phase 3 · Chronic Inducible Urticaria
Full Press Release Details
HAMPTON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the upcoming Cantor Global Healthcare Conference on September 10, 2026 at 8:00am ET.
The webcast of the presentation will be available on the “ Events and Presentations ” page of the “Investors” section of the Celldex Website. Replays will be available for 90 days following the event.
About Celldex Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. Visit www.celldex.com.
Company Contacts Sarah Cavanaugh Senior Vice President, Corporate Affairs & Administration (508) 864-8337 scavanaugh@celldex.com
Frequently Asked Questions
When will Celldex present at the conference?
Celldex will present at the Cantor Global Healthcare Conference on September 10, 2026.
How can I access the presentation?
The presentation will be available via webcast on Celldex's website.
How long will the replay of the presentation be available?
Replays of the presentation will be available for 90 days after the event.
What is Celldex's focus in immunology?
Celldex is focused on developing novel antibody-based therapies for immune disorders.